MedTrace Logo

Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

NCT01441609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2011-09-28

No results posted yet for this study

Summary

An observational study will be performed in subjects aged 3-65 years old to describe the dynamic changes of cellular immunity after vaccination of hepatitis B vaccine, and to find out the expression levels of Th9 cells and IL9 in subjects with different response to the primary immunization (3 single -dose injunctions).

Conditions

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    lead OTHER

Principal Investigators

  • Wu Jiang · main investigator

Eligibility

Min Age
3 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-04-30
Completion
2012-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441609 on ClinicalTrials.gov